Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

[Specific brain antigens as the indicators of the blood-brain barrier permeability in Alzheimer's disease].

Groppa SA, Chekhonin VP.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1991;91(9):50-2. Russian.

PMID:
1723824
2.
3.

[Immunoenzymatic detection of specific brain antigens as a criterion of the permeation of blood-brain barrier in rats with acute cerebral ischemia].

Chekhonin VP, Morozov GV, Markovkin VM, Blizniukova AS.

Biull Eksp Biol Med. 1988 May;105(5):581-3. Russian.

PMID:
2454685
4.

Immunochemical assay of glia-specific antigens as a criterion for blood-brain barrier permeability in rats during acute intoxication with sodium barbital.

Ryabukhin IA, Artemkina IV, Gurina OI, Sergienko VI, Chekhonin VP.

Bull Exp Biol Med. 2001 May;131(5):502-4.

PMID:
11550067
5.

Humoral immunity in brain aging and Alzheimer's disease.

Bouras C, Riederer BM, Kövari E, Hof PR, Giannakopoulos P.

Brain Res Brain Res Rev. 2005 Jun;48(3):477-87. Epub 2004 Oct 28. Review.

PMID:
15914253
6.

Enzyme-linked immunosorbent assay for human autoantibody to glial fibrillary acidic protein: higher titer of the antibody is detected in serum of patients with Alzheimer's disease.

Tanaka J, Nakamura K, Takeda M, Tada K, Suzuki H, Morita H, Okado T, Hariguchi S, Nishimura T.

Acta Neurol Scand. 1989 Dec;80(6):554-60.

PMID:
2618583
7.

[Permeability of the hemato-encephalic barrier in critical states due to febrile schizophrenia].

Morozov GV, Morkovkin VM, Chekhonin VP, Kekelidze ZI.

Zh Nevropatol Psikhiatr Im S S Korsakova. 1988;88(5):107-9. Russian.

PMID:
3137751
8.

Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.

Poduslo JF, Curran GL, Wengenack TM, Malester B, Duff K.

Neurobiol Dis. 2001 Aug;8(4):555-67.

PMID:
11493021
9.

Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.

Matsumoto Y, Yanase D, Noguchi-Shinohara M, Ono K, Yoshita M, Yamada M.

Dement Geriatr Cogn Disord. 2007;23(4):241-5. Epub 2007 Feb 19.

10.

[Solid-phase immunosorption of antibodies against specific brain antigen from the blood of rats with experimental break of the blood-brain barrier].

Chekhonin VP, Morozov GV, Cherkasova TA, Leĭkin IuA.

Dokl Akad Nauk SSSR. 1988;302(6):1511-3. Russian. No abstract available.

PMID:
2466629
12.

Occurrence of HLA-DR reactive microglia in Alzheimer's disease.

McGeer PL, Itagaki S, Tago H, McGeer EG.

Ann N Y Acad Sci. 1988;540:319-23. No abstract available.

PMID:
3061340
13.

Antivascular antibodies in the sera of patients with senile dementia of the Alzheimer's type.

Fillit HM, Kemeny E, Luine V, Weksler ME, Zabriskie JB.

J Gerontol. 1987 Mar;42(2):180-4.

PMID:
2950160
14.

Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease.

Lue LF, Yan SD, Stern DM, Walker DG.

Curr Drug Targets CNS Neurol Disord. 2005 Jun;4(3):249-66. Review.

PMID:
15975028
15.
16.
17.

Chloroquine administration in mice increases beta-amyloid immunoreactivity and attenuates kainate-induced blood-brain barrier dysfunction.

Mielke JG, Murphy MP, Maritz J, Bengualid KM, Ivy GO.

Neurosci Lett. 1997 May 23;227(3):169-72.

PMID:
9185677
18.
19.
20.

Serum autoantibodies against glial fibrillary acidic protein in brain aging and senile dementias.

Mecocci P, Parnetti L, Donato R, Santucci C, Santucci A, Cadini D, Foà E, Cecchetti R, Senin U.

Brain Behav Immun. 1992 Sep;6(3):286-92.

PMID:
1392102

Supplemental Content

Support Center